Skip to main content

Table 3 Clinical outcomes in-hospital period and follow up.

From: Concomitant renal insufficiency and diabetes mellitus as prognostic factors for acute myocardial infarction

 

Group I (n = 5702)

Group II (n = 1731)

Group III (n = 1432)

Group IV (n = 1044)

p Value

     

Overall

Linear†

In-hospital outcomes (n = 9905)

      

   In-hospital death (%)

168(3)

66(4)

249(18)

185(18)‡

< 0.001

< 0.001

1-month outcomes

      

   Composite MACE (%)

327 (5.7)

128(7.4)¶

317(22.2)

257(24.6)‡

< 0.001

< 0.001

   Death (%)

225(3.9)

84(4.9)

296(20.7)

226(21.6)‡

< 0.001

< 0.001

   MI (%)

28(0.5)

12(0.7)

4(0.3)

19(1.8)‡

< 0.001

0.001

   Re-PCI (%)

57(1.0)

21(1.2)

16(1.1)

7(0.7)

0.559

0.649

   CABG (%)

17(0.3)

11(0.6)

1(0.1)

5(0.5)

0.039

0.807

12-month outcomes

      

   Composite MACE (%)

715 (12.5)

271 (15.7)¶

436 (30.5)

381 (36.5)‡§

< 0.001

< 0.001

   Death (%)

287(5.0)

117 (6.8)¶

361 (25.3)

287 (27.5)‡

< 0.001

< 0.001

   MI (%)

44(0.8)

20 (1.2)

10 (0.7)

25 (2.4)‡§

< 0.001

< 0.001

   Re-PCI (%)

385(6.3)

120 (6.9)

59 (4.1)

62 (5.9)§

0.006

0.082

   CABG (%)

26 (0.5)

14 (0.8)

6 (0.4)

7 (0.7)

0.280

0.455

  1. Groups are as in Table 1.
  2. Abbreviations: MACE, major adverse cardiac event; MI, myocardial infarction; Re-PCI, target lesion revascularization; CABG, coronary artery bypass graft.
  3. †Statistical significance for linear-by-linear association between categorical variables calculated using chi-square-test for trend.
  4. ¶ p < 0.05 Compared with Group I.
  5. ‡p < 0.05 Compared with Group II.
  6. § p < 0.05 Compared with Group III.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840